Common Stock, Shares, Issued of Akari Therapeutics Plc from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Akari Therapeutics Plc quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • Akari Therapeutics Plc Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 65,229,461,523, a 169% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Akari Therapeutics Plc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 65,229,461,523 +40,940,230,000 +169% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 65,229,461,523 +65,206,336,635 +281975% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 57,752,981,523 +41,779,860,225 +262% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 53,186,919,523 +39,952,604,225 +302% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 24,289,231,523 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 23,124,888 -10,099,196,635 -100% 30 Jun 2024 8-K 06 Sep 2024
Q1 2024 15,973,121,298 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 13,234,315,298 +13,212,602,050 +60850% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q2 2023 10,122,321,523 +4,187,404,400 +71% 30 Jun 2023 6-K 29 Sep 2023 2023 Q2
Q4 2022 21,713,248 -4,738,018,675 -100% 31 Dec 2022 8-K 06 Sep 2024
Q2 2022 5,934,917,123 +1,969,938,100 +50% 30 Jun 2022 6-K 27 Sep 2022 2022 Q2
Q4 2021 4,759,731,923 0 0% 31 Dec 2021 20-F 01 May 2023 2022 FY
Q2 2021 3,964,979,023 +578,405,910 +17% 30 Jun 2021 6-K 22 Sep 2021 2021 Q2
Q4 2020 4,759,731,923 +2,513,866,010 +112% 31 Dec 2020 20-F 16 May 2022 2021 FY
Q2 2020 3,386,573,113 +1,735,879,700 +105% 30 Jun 2020 6-K 01 Sep 2020 2020 Q2
Q4 2019 2,245,865,913 +665,172,500 +42% 31 Dec 2019 20-F 21 Apr 2021 2020 FY
Q2 2019 1,650,693,413 +125,000,020 +8.2% 30 Jun 2019 6-K 29 Aug 2019 2019 Q2
Q1 2019 1,585,693,413 31 Mar 2019 20-F 21 Apr 2021 2020 FY
Q4 2018 1,580,693,413 +55,000,020 +3.6% 31 Dec 2018 20-F 31 Mar 2020 2019 FY
Q2 2018 1,525,693,393 +348,000,000 +30% 30 Jun 2018 6-K 27 Sep 2018 2018 Q2
Q4 2017 1,525,693,393 +348,000,010 +30% 31 Dec 2017 20-F 23 Apr 2019 2018 FY
Q2 2017 1,177,693,393 +10 0% 30 Jun 2017 6-K 10 Aug 2017 2017 Q2
Q4 2016 1,177,693,383 0 0% 31 Dec 2016 20-F 18 Jul 2018 2017 FY
Q2 2016 1,177,693,383 +1,122,057,100 +2017% 30 Jun 2016 6-K 14 Apr 2017 2016 Q2
Q1 2016 1,177,693,383 +1,122,057,100 +2017% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 1,177,693,383 +455,347,783 +63% 31 Dec 2015 6-K 14 Apr 2017 2016 Q2
Q3 2015 1,177,693,383 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 55,636,283 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 55,636,283 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 722,345,600 +682,117,647 +1696% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q4 2013 40,227,953 0 0% 31 Dec 2013 10-K 11 Feb 2015 2014 FY
Q4 2012 40,227,953 +28,129,356 +233% 31 Dec 2012 20-F 24 Mar 2014 2013 FY
Q4 2011 12,098,597 31 Dec 2011 20-F/A 19 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.